The effect of thymectomy on autoreactive T- and B-lymphocytes in myasthenia gravis

被引:10
作者
Ahlberg, R
Yi, Q
Pirskanen, R
Matell, G
Sundevall, AC
Aberg, B
Lefvert, AK
机构
[1] KAROLINSKA HOSP,SECT HEMATOL & IMMUNOL,DEPT MED,S-17176 STOCKHOLM,SWEDEN
[2] KAROLINSKA HOSP,DEPT THORAC SURG,S-17176 STOCKHOLM,SWEDEN
[3] SODERSJUKHUSET HOSP,DEPT NEUROL,S-11883 STOCKHOLM,SWEDEN
关键词
myasthenia gravis; thymectomy; thymus; T lymphocyte; cytokines;
D O I
10.1016/S0165-5728(96)00204-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eleven patients with myasthenia gravis were followed for three years after thymectomy. Acetylcholine receptor-specific T-cell stimulation was found in 8/11 patients before operation as compared to 2/11 three years after thymectomy. Changes of T-cell antireceptor-reactivity were commonly paralleled by changes in disease severity. The numbers of cells secreting IL-2 upon stimulation with human acetylcholine receptor correlated with those secreting IFN-gamma. T-cell reactivity against a monoclonal acetylcholine receptor antibody did not decrease after thymectomy. Such reactivity could reflect a beneficial immune response counteracting anti-receptor reactivity. The frequency of autoantibody-secreting cells remained unchanged, while the serum concentration of acetylcholine receptor antibodies started to decrease one year after thymectomy. All examined thymus-cell suspensions contained autoreactive T- and B-lymphocytes. There was a preferential enrichment of autoreactive lymphocytes in the thymus in a few patients with recent onset of disease.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 46 条
[1]   TREATMENT OF MYASTHENIA-GRAVIS WITH ANTI-CD4 ANTIBODY - IMPROVEMENT CORRELATES TO DECREASED T-CELL AUTOREACTIVITY [J].
AHLBERG, R ;
YI, Q ;
PIRSKANEN, R ;
MATELL, G ;
SWERUP, C ;
RIEBER, EP ;
RIETHMULLER, G ;
HOLM, G ;
LEFVERT, AK .
NEUROLOGY, 1994, 44 (09) :1732-1737
[2]   PROGNOSIS OF MYASTHENIA-GRAVIS - A MULTICENTER FOLLOW-UP-STUDY OF 844 PATIENTS [J].
BEGHI, E ;
ANTOZZI, C ;
BATOCCHI, AP ;
CORNELIO, F ;
COSI, V ;
EVOLI, A ;
LOMBARDI, M ;
MANTEGAZZA, R ;
MONTICELLI, ML ;
PICCOLO, G ;
TONALI, P ;
TREVISAN, D ;
ZARRELLI, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 106 (02) :213-220
[3]  
BERRIH S, 1981, CLIN EXP IMMUNOL, V45, P1
[4]   DEPLETION OF HELPER INDUCER T-CELLS AFTER THYMECTOMY IN MYASTHENIC PATIENTS [J].
BERRIH, S ;
LEBRIGAND, H ;
LEVASSEUR, P ;
GAUD, C ;
BACH, JF .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 28 (02) :272-281
[5]   VALUE OF THYMECTOMY IN MYASTHENIA-GRAVIS - COMPUTER-ASSISTED MATCHED STUDY [J].
BUCKINGHAM, JM ;
HOWARD, FM ;
BERNATZ, PE ;
PAYNE, WS ;
HARRISON, EG ;
OBRIEN, PC ;
WEILAND, LH .
ANNALS OF SURGERY, 1976, 184 (04) :453-458
[6]   PATHOLOGY OF THYMUS GLAND IN MYASTHENIA GRAVIS [J].
CASTLEMAN, B .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1966, 135 (A1) :496-+
[7]   FOLLOW-UP OF SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS AFTER THYMECTOMY IN PATIENTS WITH MYASTHENIA-GRAVIS [J].
COHENKAMINSKY, S ;
JACQUES, Y ;
AIME, C ;
SAFAR, D ;
MOREL, E ;
BERRIH-AKNIN, S .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 62 (02) :190-198
[8]  
COX A, 1986, ANN NEUROL, V19, P297, DOI 10.1002/ana.410190314
[9]  
EIMOTO T, 1989, AM J CLIN PATHOL, V94, P36
[10]  
ENGEL AG, 1977, MAYO CLIN PROC, V52, P267